Osteoarthritis treatment
(1 Pages)
Dafalgan effervescent tablet 500 mg 16 pcs
Dafalgan effervescent tablets contain the active ingredient paracetamol, which has a pain-relieving and fever-reducing effect. Dafalgan 500 mg and 1 g effervescent tablets are used for the short-term treatment of headaches, toothache, pain in the area of joints and ligaments, back pain, pain during menstruation, pain after injuries (e.g. sports injuries), pain from colds and fever. Dafalgan 1g Effervescent Tablets are also prescribed to treat osteoarthritis pain. Dafalgan 1g effervescent tablets are only available with a doctor's prescription. Swissmedic-approved patient informationDAFALGAN® effervescent tabletsUPSA Switzerland AGWhat are Dafalgan effervescent tablets and when are they used? Dafalgan effervescent tablets contain the active ingredient paracetamol, which has an analgesic and antipyretic effect. Dafalgan 500 mg and 1 g effervescent tablets are used for the short-term treatment of headaches, toothache, pain in the area of joints and ligaments, back pain, pain during menstruation, pain after injuries (e.g. sports injuries), pain from colds and fever. Dafalgan 1g Effervescent Tablets are also prescribed to treat osteoarthritis pain. Dafalgan 1g effervescent tablets are only available with a doctor's prescription. When should Dafalgan effervescent tablets not be taken?Dafalgan effervescent tablets should not be taken in the following cases: In case of hypersensitivity to the active ingredient paracetamol or any other ingredient (see «What does Dafalgan effervescent tablets contain?»). Such hypersensitivity manifests itself e.g. through asthma, shortness of breath, circulatory problems, low blood pressure, swelling of the skin and mucous membranes or skin rashes (urticaria);In the case of severe liver diseases;In the case of a hereditary liver disorder ( so-called Meulengracht disease).When should caution be taken when taking Dafalgan effervescent tablets?In diseases of the kidneys or the liver as well as If you have a so-called "glucose-6-phosphate dehydrogenase deficiency" (rare hereditary disease of the red blood cells), you should consult your doctor before taking it. Also tell your doctor if you are also taking blood-thinning medicines or certain medicines used to treat tuberculosis (rifampicin, isoniazid), epilepsy (phenytoin, carbamazepine), gout (probenecid), high blood fat levels (cholestyramine) or HIV- infections (zidovudine). Caution is also required when using drugs containing the active ingredients chloramphenicol, salicylamide or phenobarbital at the same time. Your doctor must also be informed if you are using an antibiotic with the active substance flucloxacillin at the same time, as there is an increased risk of acidification of the blood (metabolic acidosis with increased anion gap). Close medical monitoring is recommended to detect the onset of metabolic acidosis. Alcohol consumption is not recommended during treatment with Dafalgan. The risk of liver damage increases, especially if you do not eat at the same time. Drugs containing the active ingredient paracetamol must not be given to children who have accidentally consumed alcohol. Dafalgan should be used with caution in the case of eating disorders such as anorexia, bulimia and severe emaciation, as well as chronic malnutrition. Diafalgan should be taken with caution if you are dehydrated or have reduced blood levels. If you have a severe infection (e.g. blood poisoning), caution should also be exercised when using Dafalgan. This medicine contains sorbitol. One Dafalgan 500 mg effervescent tablet contains 300 mg sorbitol. One Dafalgan 1 g effervescent tablet contains 252 mg sorbitol. Sorbitol is a source of fructose. Talk to your doctor before you (or your child) take or receive this medicine if your doctor has told you that you (or your child) have an intolerance to some sugars or if you have Hereditary Fructose Intolerance (HFI) - a rare congenital condition in which a person cannot break down fructose - has been identified. One Dafalgan 1g effervescent tablet contains 39mg of aspartame. Aspartame is a source of phenylalanine. It can be harmful if you have phenylketonuria (PKU), a rare inherited disorder in which phenylalanine builds up because the body can't break it down enough. This medicine contains benzoate. One Dafalgan 500 mg effervescent tablet contains 51 mg benzoate. One Dafalgan 1 g effervescent tablet contains 101 mg benzoate. Benzoate can increase jaundice (yellowing of the skin and eyes) in newborn babies (up to 4 weeks of age). This medicine contains sodium (main component of cooking/table salt). One Dafalgan 500 mg effervescent tablet contains 412.3 mg sodium. This equates to 21% of the recommended maximum daily dietary intake of sodium for an adult. One Dafalgan 1 g effervescent tablet contains 565.5 mg sodium. This equates to 28% of the recommended maximum daily dietary intake of sodium for an adult. Talk to your doctor or pharmacist, especially if you are on a low-salt (low-sodium) diet. Individuals who are hypersensitive to painkillers or anti-rheumatic drugs may also be hypersensitive to paracetamol (see «What side effects can Dafalgan effervescent tablets have?»). It is also important to remember that long-term, frequent use of painkillers can itself contribute to headaches developing or making existing headaches worse. In such cases, contact your doctor. Long-term use of painkillers, especially when several painkillers are combined, can lead to permanent kidney damage with the risk of kidney failure. To avoid the risk of overdose, it should be ensured that other medications administered do not contain paracetamol. Tell your doctor, pharmacist or druggist if you suffer from other illnesses,have allergies ortake other medicines (including those you bought yourself!) or use them externally!Can Dafalgan effervescent tablets be taken during pregnancy or while breastfeeding?As a precautionary measure, you should avoid taking medicines during pregnancy and breastfeeding or consult a doctor, pharmacist or druggist or ask the doctor, pharmacist or druggist for advice. If necessary, Dafalgan effervescent tablets can be used during pregnancy. Based on previous experience, currently with short-term use of the active substance paracetamol in the specified dosage, the risk for the child is considered low. You should use the lowest dose that relieves your pain and/or fever and you should use the medicine for the shortest possible time. Contact your doctor, pharmacist or druggist if the pain and/or fever does not improve or you need to take the medicine more often. Although the use of paracetamol is considered compatible with breast-feeding, caution should be exercised when using Dafalgan effervescent tablets during breast-feeding as paracetamol is excreted in breast milk. How do you use Dafalgan effervescent tablets?The analgesic effect of Dafalgan effervescent tablets occurs twice as fast as with paracetamol tablets. The effervescent tablets are best dissolved in a large glass of water to create a clear solution. Do not chew or swallow the tablets. Do not administer single doses of the effervescent tablets more frequently than indicated. The specified maximum daily dose must not be exceeded. Dafalgan Effervescent Tablets 1g should not be taken by adults and children under 50kg as this can lead to overdose (more than the recommended dose) and thus liver damage. Do not use Dafalgan effervescent tablets 500 mg in children under the age of 6 years. Effervescent tablets with a score line (divisible) of 500 mg:Adults and adolescents over 12 years of age (over 40 kg): 1-2 effervescent tablets of 500 mg as a single dose, wait 4-8 hours before taking the next dose. The maximum dose per day is 8 effervescent tablets of 500 mg (= 4 g paracetamol). Children 30-40 kg (9-12 years):1 500 mg effervescent tablet as a single dose, wait 6-8 hours before taking the next dose. The maximum dose per day is 4 effervescent tablets of 500 mg (= 2 g paracetamol). Children 22-30 kg (6-9 years):½-1 500 mg effervescent tablet as a single dose, wait 6-8 hours before taking the next dose. The maximum dose per day is 3 effervescent tablets of 500 mg (= 1.5 g paracetamol). Effervescent tablets with a decorative groove of 1 g:Adults and adolescents over 15 years (over 50 kg): 1 effervescent tablet of 1 g as a single dose, wait 4-8 hours before taking the next dose. The maximum dose per day is 4 effervescent tablets of 1 g (= 4 g paracetamol). The 1 g effervescent tablets must not be divided along the decorative groove. Do not use Dafalgan for more than 5 days or 3 days if you have a fever, unless prescribed by a doctor. For children up to 12 years of age, the maximum continuous period of use without a doctor's consultation is 3 days. Painkillers should not be taken regularly for a long period of time (adults no longer than 5 days, children no longer than 3 days) without medical supervision. Long-lasting pain requires a medical evaluation. High fever or worsening condition in children requires early medical consultation. The dosage specified or prescribed by the doctor must not be exceeded. Follow the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist. What side effects can Dafalgan effervescent tablets have?The following side effects can occur when taking Dafalgan effervescent tablets: In rare cases, skin reddening or allergic reactions with sudden swelling of the face and neck or sudden malaise with a drop in blood pressure may occur. Furthermore, shortness of breath or asthma may occur, especially if these side effects have also been observed previously with the use of acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs). If signs of a hypersensitivity reaction or bruising/bleeding occur, the drug should be discontinued and the doctor consulted. Rarely, changes in the blood picture have been observed, such as a reduced number of blood platelets (thrombocytopenia) or a severe reduction in the number of certain white blood cells (agranulocytosis; neutropenia, leucopenia). A certain disease of the bone marrow (pancytopenia) and a certain form of anemia (haemolytic anemia) have also been observed rarely. Other side effects, the frequency of which is currently unknown, include diarrhoea, abdominal pain, vomiting, increase in liver enzymes, bile stasis, jaundice, blood spots on the skin and flushing. Hives, skin rashes and rashes have also occasionally been observed. Severe skin diseases (acute generalized exanthematous pustulosis, toxic epidermal necrolysis, Steven-Johnson syndrome) with blistering, desquamation and flu-like symptoms have occurred very rarely. In the event of uncontrolled intake (overdose), a doctor must be consulted immediately. Nausea, vomiting, abdominal pain, loss of appetite and/or a general feeling of illness can be an indication of an overdose, but only occur several hours to a day after ingestion. An overdose can cause very serious liver damage or, in rare cases, sudden inflammation of the pancreas. If you get any side effects, talk to your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet. What else needs to be considered?Shelf lifeThe medicinal product may only be used up to the date marked on the container with « EXP» can be used. Storage instructionsThe medicine should be stored at room temperature (15-25 °C), protected from moisture and out of the reach of children. Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists. What does Dafalgan effervescent tablets contain?Active ingredients1 Dafalgan 500 mg effervescent tablet contains:500 mg paracetamol as active ingredient. 1 Dafalgan 1 g effervescent tablet contains:1 g paracetamol as the active ingredient. Excipients1 Dafalgan 500 mg effervescent tablet contains:Citric acid, anhydrous (E 330), sodium bicarbonate, sodium carbonate , anhydrous (E500), sorbitol (E420), docusate sodium, povidone, sodium saccharin (E954) and sodium benzoate (E211). 1 Dafalgan 1 g effervescent tablet contains:citric acid, anhydrous (E 330), sodium bicarbonate, sodium carbonate, anhydrous (E 500), sorbitol (E 420), docusate Sodium, Povidone, Sodium Benzoate (E211), Aspartame (E951), Acesulfame Potassium (E950), Grapefruit Flavor, Orange Flavor. Approval number47503 (Swissmedic). Where can you get Dafalgan effervescent tablets? What packs are available? In pharmacies and drugstores, without a doctor's prescription: Dafalgan 500 mg scored, divisible: box of 16 effervescent tablets. In pharmacies, only with a doctor's prescription: Dafalgan 1g scored: boxes of 20 effervescent tablets. Authorization holderUPSA Switzerland AG, Zug. This leaflet was last checked by the drug authority (Swissmedic) in April 2022. ..
6.47 USD
Flector ep tissugel pfl 10 pcs
Flector EP Tissugel is a self-adhesive, flexible patch to be placed on the skin, containing the active ingredient diclofenac, a substance with analgesic and anti-inflammatory properties. Flector EP Tissugel is indicated for the local and symptomatic treatment of osteoarthritis of the knee (gonarthrosis). Flector EP Tissugel is used for the local treatment of pain, inflammation and swelling as a result of sprains, dislocations, bruises and strains. Swissmedic-approved patient informationFlector EP Tissugel®IBSA Institut Biochimique SAWhat is Flector EP Tissugel and when is it used? Flector EP Tissugel is a self-adhesive, flexible patch to be placed on the skin, containing the active ingredient diclofenac, a substance with analgesic and anti-inflammatory properties. Flector EP Tissugel is indicated for the local and symptomatic treatment of osteoarthritis of the knee (gonarthrosis). Flector EP Tissugel is used for the local treatment of pain, inflammation and swelling as a result of sprains, dislocations, bruises and strains. When not to use Flector EP Tissugel?Do not use Flector EP Tissugel:If you are hypersensitive to the active substance or to an excipient according to the composition (see «What does Flector EP Tissugel contain?»), If you are hypersensitive to other painkillers and anti-inflammatory drugs (e.g. acetylsalicylic acid). Flector EP Tissugel must not be used on open wounds (e.g. skin abrasions, cuts, etc.) or on eczematous skin. When is caution required when using Flector EP Tissugel?Flector EP Tissugel must not come into contact with the eyes and mucous membranes. Tell your doctor, pharmacist or druggist if you: have already used similar products (rheumatism ointments) and these have led to allergic reactions, Suffer from other illnesses, have allergies or take other medicines (including those you bought yourself!) or use them externally. Can Flector EP Tissugel be used while pregnant or breastfeeding?As a precautionary measure, you should not use Flector EP Tissugel while pregnant or breastfeeding, unless expressly stated medical prescription. How do you use Flector EP Tissugel?Twice a day, morning and evening, 1 self-adhesive plaster is applied to the skin area to be treated. Before use, remove the clear film that protects the gelatinous surface. Instructions for use: see image on the bag. If the patch does not adhere well, as may be the case on the elbow, knee or ankle, use the elastic mesh stocking included in the pack for additional fixation. The duration of treatment should not exceed 14 days. The use of Flector EP Tissugel in children has not been systematically evaluated. Stick to the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist. What side effects can Flector EP Tissugel have?Flector EP Tissugel is generally well tolerated. The following side effects may occur when using Flector EP Tissugel: Itching, redness, swelling or blistering at the treated area. Very rarely, severe skin rashes, allergic reactions such as wheezing, shortness of breath or facial swelling, or increased sensitivity to sunlight have been observed. If any of the following side effects occur, stop using Flector EP Tissugel and tell your doctor immediately: severe skin rash, wheezing, shortness of breath or swelling of the face. If you notice side effects that are not described here, you should inform your doctor, pharmacist or druggist. What else needs to be considered?The medicine should be stored at room temperature (15-25 °C) and out of the reach of children. The medicinal product may only be used up to the date marked «EXP» on the container. Once the envelope is first opened, the patches should be used within 3 months. After cutting, the packaging can be resealed at any time so that the patches retain their moisture. Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists. What does Flector EP Tissugel contain?Active ingredients: Diclofenac Epolamine, 182 mg per patch (corresponding to a concentration of 1.3% diclofenac epolamine, or 1% diclofenac sodium salt). Excipients: propylene glycol, preservative: propyl parahydroxybenzoate (E216), methyl parahydroxybenzoate (E218), flavorings. Approval number52022 (Swissmedic). Where can you get Flector EP Tissugel? What packs are available?In pharmacies and drugstores, without a doctor's prescription. Packs of 2, 5, 10 and 15 patches. Packs of elastic fishnet stockings. Authorization holderIBSA Institut Biochimique SA, Lugano. This leaflet was last checked by the Medicines Agency (Swissmedic) in November 2016. ..
78.49 USD
Ostenil inj lös 20 mg/2ml fertspr
Ostenil Inj Lös 20mg/2ml Fertspr Ostenil Inj Lös 20mg/2ml Fertspr is a sterile injectable solution containing a high concentration of hyaluronic acid. This product is used to treat osteoarthritis and other joint disorders, providing long-lasting pain relief and improving joint mobility. What is Ostenil Inj Lös 20mg/2ml Fertspr? Ostenil Inj Lös 20mg/2ml Fertspr is a medical device designed to treat osteoarthritis and other forms of joint disorder. The product contains hyaluronic acid, a natural substance that lubricates and cushions the joints. The injectable solution is administered directly into the joint, providing pain relief and improving joint mobility. This product is particularly effective in cases where other treatments have failed to provide adequate relief. How does Ostenil Inj Lös 20mg/2ml Fertspr work? As we age, our bodies produce less and less hyaluronic acid, a substance that lubricates and cushions the joints. This can lead to joint pain and stiffness, particularly in the knee and other weight-bearing joints. By injecting Ostenil Inj Lös 20mg/2ml Fertspr directly into the joint, we can increase the concentration of hyaluronic acid, restoring lubrication and cushioning to the joint. This has the effect of reducing pain and inflammation, and improving joint mobility. What are the benefits of Ostenil Inj Lös 20mg/2ml Fertspr? Ostenil Inj Lös 20mg/2ml Fertspr has a number of benefits, including: Pain relief: The product provides long-lasting pain relief, reducing inflammation and stiffness in the joint. Improved joint mobility: By restoring natural lubrication and cushioning to the joint, Ostenil Inj Lös 20mg/2ml Fertspr can improve joint mobility and flexibility. Non-invasive treatment: Unlike joint replacement surgery, Ostenil Inj Lös 20mg/2ml Fertspr is a non-invasive treatment option that does not require hospitalization or a lengthy recovery period. Effective in cases where other treatments have failed: Ostenil Inj Lös 20mg/2ml Fertspr is particularly effective in cases where other treatments, such as painkillers or physical therapy, have failed to provide adequate relief. Who can benefit from Ostenil Inj Lös 20mg/2ml Fertspr? Ostenil Inj Lös 20mg/2ml Fertspr is suitable for anyone suffering from osteoarthritis or other joint disorders, particularly those experiencing joint pain, inflammation, and stiffness. The product is also suitable for individuals who have failed to respond to other treatments, such as painkillers or physical therapy. How is Ostenil Inj Lös 20mg/2ml Fertspr administered? Ostenil Inj Lös 20mg/2ml Fertspr is administered by injection directly into the joint. The product is sterile and should only be administered by a qualified medical professional. The number and frequency of injections will depend on the severity of the joint disorder and the patient's response to treatment. Is Ostenil Inj Lös 20mg/2ml Fertspr safe? Ostenil Inj Lös 20mg/2ml Fertspr is a safe and well-tolerated treatment option for osteoarthritis and other joint disorders. As with any medical treatment, there is a small risk of side effects, including redness, swelling, and pain at the injection site. However, these side effects are usually mild, and patients can resume normal activities immediately after the injection. ..
88.37 USD
Ostenil mini inj lös 10 mg/1ml fertspr
Ostenil mini Inj Loes 10 mg / 1 ml Fertspr Ostenil mini Injection Solution contains 10mg/ml of sodium hyaluronate and is used to treat joint pain caused by osteoarthritis. The hyaluronic acid in Ostenil mini is a natural substance found in the body and serves as a shock absorber and lubricant in the joints. This product is designed for those who suffer from mild to moderate osteoarthritis and provides lasting relief from pain and stiffness. With regular use, it can help to restore joint function and improve mobility. Ostenil mini Injection Solution is administered by injection directly into the joint and is quick and easy to use. The small size of the syringe means that the injection is relatively painless and requires minimal downtime afterwards. Benefits of using Ostenil mini Injection Solution include: Effective relief from joint pain and stiffness Improvement in joint function and mobility Long-lasting results with regular use Quick and easy injection process Minimal downtime If you suffer from osteoarthritis and are looking for an effective way to manage your joint pain, Ostenil mini Injection Solution could be the solution you have been looking for. Speak to your doctor or healthcare professional to find out if it is right for you...
58.32 USD
Suplasyn inj loes 20mg/2ml fertspr 2ml
Suplasyn Inj Loes 20mg/2ml Fertspr 2ml - Hyaluronic Acid for Joint Health Are you tired of dealing with the pain and stiffness of osteoarthritis? Suplasyn Inj Loes is a safe and effective treatment that can help alleviate your symptoms. This hyaluronic acid injection works by lubricating your joints, reducing friction, and cushioning the cartilage. Benefits of Suplasyn Inj Loes: Reduces joint pain and stiffness Improves mobility and range of motion Slows down the progression of osteoarthritis Non-invasive and minimally invasive procedure Suplasyn Inj Loes is a highly purified hyaluronic acid solution that is biocompatible with the human body. It is a popular choice for individuals seeking a natural and effective way to manage osteoarthritis pain. Don't let joint pain limit your activities. Order your Suplasyn Inj Loes today and experience the difference! Indication Arthrosis (improvement of the rheological properties of the synovial fluid) Dosage Intra-articular injection. Suplasyn 20 mg/2 ml and Suplasyn 1-Shot 60 mg/6 ml: for large joints; Suplasyn md 7 mg/0.7 ml: for small joints.Suplasyn/Suplasyn md:Adults: 3 injections in wö at regular intervals. Multiple joints can be treated at the same time. Repeated treatment cycles are possible.Suplasyn 1-Shot:Adults: 1 single injection. Contraindication Joint infections; acute attacks of osteoarthritis; joint effusion; Skin lesions at the injection site; Pregnancy; Breastfeeding..
76.01 USD
(1 Pages)